Early cerebral hypoxia in extremely preterm infants and neurodevelopmental impairment at 2 year of age: A post hoc analysis of the SafeBoosC II trial

BACKGROUND: The SafeBoosC II, randomised clinical trial, showed that the burden of cerebral hypoxia was reduced with the combination of near infrared spectroscopy and a treatment guideline in extremely preterm infants during the first 72 hours after birth. We have previously reported that a high bur...

Descripción completa

Detalles Bibliográficos
Autores principales: Plomgaard, Anne Mette, Schwarz, Christoph E., Claris, Olivier, Dempsey, Eugene M., Fumagalli, Monica, Hyttel-Sorensen, Simon, Lemmers, Petra, Pellicer, Adelina, Pichler, Gerhard, Greisen, Gorm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786171/
https://www.ncbi.nlm.nih.gov/pubmed/35073354
http://dx.doi.org/10.1371/journal.pone.0262640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786171/
https://www.ncbi.nlm.nih.gov/pubmed/35073354
http://dx.doi.org/10.1371/journal.pone.0262640

Ejemplares similares